Imperial College London completes ACTION hypertension study in Nigeria and Sri Lanka
Registry record shows completed mixed-methods study assessing hypertension care and treatment strategies across primary care settings in the two countries.
This week's registry update covers a single observational study sponsored by Imperial College London with several academic collaborators.
- "A Low-Cost, Scalable Treatment Strategy for Improving Hypertension Control in Low and Middle-Income Settings: Formative Phase (Aim 1)," registered under NCT07784647 and acronym ACTION, is listed as completed. The study is described as a cross-sectional mixed-methods observational study including facility assessments (SARA), patient surveys, and qualitative interviews1, with actual enrollment of 1444 participants and a primary completion date of 2026-07-21. Imperial College London is the lead sponsor, with collaborators including University of Abuja, RemediumOne, University of Kelaniya, The George Institute, The George Institute for Global Health, Australia, and The University of New South Wales1. The primary outcome measured prevalence of hypertension control at baseline, with a single study visit1, estimated separately for Nigeria and Sri Lanka.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.